Determination of Aspirin Responsiveness by Use of Whole Blood Platelet Aggregometry
Open Access
- 1 April 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 53 (4), 614-619
- https://doi.org/10.1373/clinchem.2006.081059
Abstract
Background: Insufficient platelet inhibition is associated with an increased cardiovascular risk in up to 30% of patients taking regular doses of aspirin. We describe an assay to study aspirin responsiveness.Keywords
This publication has 25 references indexed in Scilit:
- Aspirin resistanceThe Lancet, 2006
- Cyclooxygenase Inhibition and Cardiovascular RiskCirculation, 2005
- Aspirin and ClopidogrelArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Aspirin resistance: definition, mechanisms and clinical read-outsJournal of Thrombosis and Haemostasis, 2003
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJournal of the American College of Cardiology, 2003
- Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular EventsCirculation, 2002
- The TIMI Risk Score for Unstable Angina/Non–ST Elevation MIJAMA, 2000
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patientsThrombosis Research, 1993
- The electronic aggregometer: A novel device for assessing platelet behavior in bloodJournal of Pharmacological Methods, 1980